Mirallié, Eric <br/><br/>
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.  [electronic resource] 

 -  Surgery  Dec 2007 
 - 952-8; discussion 952-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1532-7361 
<br/><br/><label>Standard No.: </label>10.1016/j.surg.2007.09.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Follicular--diagnostic imaging<br/>Adenoma, Oxyphilic--diagnostic imaging<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cell Differentiation<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnostic imaging<br/>Patient Selection<br/>Positron-Emission Tomography--methods<br/>Prospective Studies<br/>Radiopharmaceuticals<br/>Thyroglobulin--blood<br/>Thyroid Neoplasms--diagnostic imaging<br/>Thyroidectomy<br/>Tomography, X-Ray Computed